Examples of Solesta Product in a sentence
To Q-Med’s knowledge, none of the Q-Med IP, the Deflux Product or the Solesta Product infringes upon, misappropriates, or misuses the intellectual property rights of any Third Party.
The Parties agree that the immediately preceding sentence shall not apply to the current Solesta Product and its components.
Within [*] months of receipt of Regulatory Approval in the U.S., QMS shall cause the Market Launch for the Solesta Product (or any other time as the Parties may agree upon in writing and subject to receipt by QMS of launch supplies of the Solesta Product from Q-Med ordered under the QMS Supply Agreement).
Upon its issuance, Q-Med shall assign the Solesta Product PMA to QMS.
What both OCA and DFS rulemaking as well as the Attorney General's enforcement actions do show is that debt collection abuses are so widespread in New York State that several agencies have identified the need, and have taken steps, to ameliorate the problems.
Notwithstanding anything herein to the contrary, Q-Med will continue to conduct the ongoing Solesta PMA Approval Clinical Trial relating to obtaining Regulatory Approval for the Solesta Product in the U.S. and the Solesta PMCS Trial in a timely manner.
Q-Med will bear all Development Costs for all such current pre-clinical studies required to be conducted by the FDA relating to the approval of the first Solesta Product in the U.S. Should FDA require additional pre-clinical studies to be performed, the parties shall share the costs for such additional pre-clinical studies.
The Purchase Prices, as so determined for Licensed Products other than the Solesta Product and the Deflux Product, shall be subject to adjustment thereafter under Section 3.2.
For clarity, any pre-clinical and clinical activities associated with the first Solesta Product in the U.S., including the Solesta PMA Approval Clinical Trial, shall not be a Project.
QMS may terminate this Agreement, effective upon not less than [*] months’ prior written notice to Q-Med if all Regulatory Approvals necessary for marketing and sale of the Solesta Product in the U.S. have not been achieved by [*], or at any time upon not less than [*] month’s prior written notice to Q-Med given following the [*] anniversary of the Market Launch of the Solesta Product.